• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Acute liver failure following atorvastatin dose escalation: is there a threshold dose for idiosyncratic hepatotoxicity?

作者信息

Carrascosa Miguel F, Salcines-Caviedes José R, Lucena M Isabel, Andrade Raul J

机构信息

Department of Internal Medicine, Hospital of Laredo, Laredo, Cantabria, Spain.

Department of Internal Medicine, Gastroenterology Section, Hospital of Laredo, Laredo, Cantabria, Spain.

出版信息

J Hepatol. 2015 Mar;62(3):751-2. doi: 10.1016/j.jhep.2014.11.019. Epub 2014 Nov 21.

DOI:10.1016/j.jhep.2014.11.019
PMID:25463547
Abstract
摘要

相似文献

1
Acute liver failure following atorvastatin dose escalation: is there a threshold dose for idiosyncratic hepatotoxicity?阿托伐他汀剂量增加后出现的急性肝衰竭：特异质性肝毒性是否存在阈值剂量？
J Hepatol. 2015 Mar;62(3):751-2. doi: 10.1016/j.jhep.2014.11.019. Epub 2014 Nov 21.
2
Hepatotoxicity of statins and other lipid-lowering agents.他汀类药物和其他降脂药物的肝毒性。
Liver Int. 2017 Feb;37(2):173-178. doi: 10.1111/liv.13308. Epub 2016 Nov 27.
3
Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing.他汀类药物相关的肝毒性：上市后报告的特异质性肝损伤。
J Hepatol. 2012 Feb;56(2):374-80. doi: 10.1016/j.jhep.2011.07.023. Epub 2011 Sep 1.
4
How low is too low: Statin induced hemolysis.
Am J Hematol. 2016 Feb;91(2):267. doi: 10.1002/ajh.24105. Epub 2015 Oct 16.
5
Severe hepatic injury associated with different statins in patients with chronic liver disease: a nationwide population-based cohort study.慢性肝病患者中不同他汀类药物相关的严重肝损伤：一项基于全国人群的队列研究。
J Gastroenterol Hepatol. 2015 Jan;30(1):155-62. doi: 10.1111/jgh.12657.
6
What Is the Appropriate Duration of High-Dose Atorvastatin Therapy Post-Acute Coronary Syndrome?急性冠状动脉综合征后大剂量阿托伐他汀治疗的合适疗程是多久？
J Pharm Pract. 2015 Dec;28(6):555-60. doi: 10.1177/0897190014544796.
7
Protective effect of arjunolic acid against atorvastatin induced hepatic and renal pathophysiology via MAPK, mitochondria and ER dependent pathways.阿朱诺酸通过丝裂原活化蛋白激酶、线粒体和内质网依赖性途径对阿托伐他汀诱导的肝脏和肾脏病理生理的保护作用。
Biochimie. 2015 May;112:20-34. doi: 10.1016/j.biochi.2015.02.016. Epub 2015 Feb 28.
8
Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report.阿托伐他汀治疗后出现严重急性胆汁淤积性肝炎伴胆汁淤积延长和胆管损伤：一例报告
Acta Gastroenterol Belg. 2008 Jul-Sep;71(3):318-20.
9
Atorvastatin associated liver disease.阿托伐他汀相关性肝病
Dig Liver Dis. 2006 Oct;38(10):772-7. doi: 10.1016/j.dld.2006.04.013. Epub 2006 Jun 13.
10
Cholestatic jaundice induced by atorvastatin: a possible association with antimitochondrial antibodies.阿托伐他汀引起的胆汁淤积性黄疸：与抗线粒体抗体的可能关联。
Isr Med Assoc J. 2009 Jul;11(7):440-1.

引用本文的文献

1
Role of Gut Microecology in the Pathogenesis of Drug-Induced Liver Injury and Emerging Therapeutic Strategies.肠道微生态在药物性肝损伤发病机制中的作用及新兴治疗策略。
Molecules. 2024 Jun 4;29(11):2663. doi: 10.3390/molecules29112663.
2
Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update.中国药物性肝损伤诊治指南：更新版。
Hepatol Int. 2024 Apr;18(2):384-419. doi: 10.1007/s12072-023-10633-7. Epub 2024 Feb 24.
3
Huotan Jiedu Tongluo Decoction Inhibits Balloon-Injury-Induced Carotid Artery Intimal Hyperplasia in the Rat through the PERK-eIF2-ATF4 Pathway and Autophagy Mediation.
化痰解毒通络方通过PERK-eIF2-ATF4通路和自噬介导抑制大鼠球囊损伤诱导的颈动脉内膜增生
Evid Based Complement Alternat Med. 2021 Jul 20;2021:5536237. doi: 10.1155/2021/5536237. eCollection 2021.
4
Evaluation of high-dose atorvastatin pretreatment influence in patients preconditioning of post coronary artery bypass graft surgery: A prospective triple blind randomized clinical trial.评价大剂量阿托伐他汀预处理对冠状动脉旁路移植术后患者预处理的影响：一项前瞻性、三盲、随机临床试验。
Ann Card Anaesth. 2021 Apr-Jun;24(2):209-216. doi: 10.4103/aca.ACA_34_19.
5
Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice.药物性肝损伤（DILI）中的氧化应激：从机制到临床实践中使用的生物标志物
Antioxidants (Basel). 2021 Mar 5;10(3):390. doi: 10.3390/antiox10030390.
6
The Impact of Statins before High-Risk CABG on Postoperative Multiple Organ Function.高危冠状动脉旁路移植术（CABG）前使用他汀类药物对术后多器官功能的影响
Cardiol Res Pract. 2020 Jan 14;2020:9519736. doi: 10.1155/2020/9519736. eCollection 2020.
7
Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors.药物性肝损伤的早期预测和及时识别策略：以细胞周期蛋白依赖性激酶4/6抑制剂为例
Front Pharmacol. 2019 Oct 24;10:1235. doi: 10.3389/fphar.2019.01235. eCollection 2019.
8
Atorvastatin mitigates cyclophosphamide-induced hepatotoxicity via suppression of oxidative stress and apoptosis in rat model.阿托伐他汀通过抑制大鼠模型中的氧化应激和细胞凋亡减轻环磷酰胺诱导的肝毒性。
Res Pharm Sci. 2018 Oct;13(5):440-449. doi: 10.4103/1735-5362.236837.
9
Recent Advances in the Histopathology of Drug-Induced Liver Injury.药物性肝损伤组织病理学的最新进展
Surg Pathol Clin. 2018 Jun;11(2):297-311. doi: 10.1016/j.path.2018.02.009.
10
Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury.药物性肝损伤的病例特征、临床特点及危险因素
Int J Mol Sci. 2016 May 12;17(5):714. doi: 10.3390/ijms17050714.